Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Acq. announced
Director departure
Merger agrmnt [a]
Appointed director

Foamix Pharmaceuticals Ltd. (FOMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/18/2020 4 STERN STANLEY (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 21,147 shares @ $0
Disposed/sold 21,212 shares @ $0
Disposed/sold 27,000 options @ $5.88, valued at $158.8k
Disposed/sold 21,562 options @ $4.76, valued at $102.6k
Disposed/sold 24,947 options @ $5.06, valued at $126.2k
Disposed/sold 12,719 options @ $3.53, valued at $44.9k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/11/2020 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 12,333 shares @ $0
Disposed/sold 91,303 shares @ $0
Disposed/sold 40,000 options @ $8.54, valued at $341.6k
Disposed/sold 13,000 options @ $5.39, valued at $70.1k
Disposed/sold 30,000 options @ $6.35, valued at $190.5k
Disposed/sold 75,997 options @ $3.77, valued at $286.5k
Disposed/sold 96,365 options @ $4.03, valued at $388.4k
03/11/2020 4 Schwartz Aharon (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 112,200 shares @ $0
Disposed/sold 24,000 options @ $11.8687, valued at $284.8k
Disposed/sold 21,435 options @ $4.687, valued at $100.5k
Disposed/sold 24,883 options @ $5.022, valued at $125k
Disposed/sold 49,412 options @ $2.66, valued at $131.4k
Disposed/sold 38,156 options @ $3.53, valued at $134.7k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/11/2020 4 Hirsch Stanley (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 52,842 shares @ $0
Disposed/sold 182,500 shares @ $0
Disposed/sold 59,016 shares @ $0
Disposed/sold 27,000 options @ $5.88, valued at $158.8k
Disposed/sold 82,153 options @ $4.69, valued at $385.3k
Disposed/sold 49,766 options @ $5.02, valued at $249.8k
03/11/2020 4 Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 12,742 shares @ $0
Disposed/sold 85,490 shares @ $0
Disposed/sold 50,000 options @ $6.35, valued at $317.5k
Disposed/sold 70,297 options @ $3.77, valued at $265k
Disposed/sold 96,365 options @ $4.03, valued at $388.4k
03/11/2020 4 Hadar Ilan (CFO & Country Manager) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 14,077 shares @ $0
Disposed/sold 116,501 shares @ $0
Disposed/sold 5,469 options @ $1.92, valued at $10.5k
Disposed/sold 24,125 options @ $5.46, valued at $131.7k
Disposed/sold 18,000 options @ $6.77, valued at $121.9k
Disposed/sold 202,004 options @ $7.13, valued at $1.4M
Disposed/sold 60,000 options @ $6.34, valued at $380.4k
Disposed/sold 60,389 options @ $10.31, valued at $622.6k
Disposed/sold 196,205 options @ $5.22, valued at $1M
Disposed/sold 35,093 options @ $6.4, valued at $224.6k
Disposed/sold 94,996 options @ $3.81, valued at $361.9k
03/11/2020 4 Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 90,902 shares @ $0
Disposed/sold 233,126 shares @ $0
Disposed/sold 18,750 options @ $7.984, valued at $149.7k
Disposed/sold 236,810 options @ $7.14, valued at $1.7M
Disposed/sold 60,000 options @ $6.04, valued at $362.4k
Disposed/sold 71,369 options @ $10.218, valued at $729.2k
Disposed/sold 327,720 options @ $5.759, valued at $1.9M
Disposed/sold 70,187 options @ $5.06, valued at $355.1k
Disposed/sold 170,993 options @ $3.77, valued at $644.6k
Disposed/sold 240,912 options @ $4.03, valued at $970.9k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/11/2020 4 Bright Rex (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Disposed/sold 27,000 options @ $5.88, valued at $158.8k
Disposed/sold 21,562 options @ $4.76, valued at $102.6k
Disposed/sold 24,947 options @ $5.06, valued at $126.2k
Disposed/sold 49,412 options @ $2.66, valued at $131.4k
Disposed/sold 38,156 options @ $3.53, valued at $134.7k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 1,761 shares @ $2.6775, valued at $4.7k
03/03/2020 4 Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 4,705 shares @ $2.6775, valued at $12.6k
03/03/2020 4 STERN STANLEY (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 14,164 shares @ $0
Granted 12,719 options to buy @ $3.53, valued at $44.9k
03/03/2020 4 Schwartz Aharon (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 38,156 options to buy @ $3.53, valued at $134.7k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Hirsch Stanley (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 42,493 shares @ $0
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Bright Rex (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 38,156 options to buy @ $3.53, valued at $134.7k
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2020 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 41,299 shares @ $0
Granted 96,365 options to buy @ $4.03, valued at $388.4k
02/24/2020 4 Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 41,299 shares @ $0
Granted 96,365 options to buy @ $4.03, valued at $388.4k
02/24/2020 4 Hadar Ilan (CFO & Country Manager) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 41,299 shares @ $0
Granted 96,365 options to buy @ $4.03, valued at $388.4k
02/24/2020 4 Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 103,248 shares @ $0
Granted 240,912 options to buy @ $4.03, valued at $970.9k
01/03/2020 4 Wiley Matthew T. (Chief Commercial Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Paid exercise price by delivering 2,500 shares @ $3.28, valued at $8.2k
01/03/2020 4 Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Paid exercise price by delivering 514 shares @ $3.28, valued at $1.7k
01/03/2020 4 Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Paid exercise price by delivering 618 shares @ $3.28, valued at $2k
01/03/2020 4 Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Paid exercise price by delivering 2,751 shares @ $3.28, valued at $9k
12/03/2019 4 Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 9,842 shares @ $2.159, valued at $21.2k
12/03/2019 4 Wiley Matthew T. (Chief Commercial Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 9,842 shares @ $2.159, valued at $21.2k
12/03/2019 4 Harsch Mutya (CLO and General Counsel) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 4,284 shares @ $2.159, valued at $9.2k
11/05/2019 4 Hirsch Stanley (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Exercised 32,500 options @ $0.62, valued at $20.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy